2012
DOI: 10.1073/pnas.1206735109
|View full text |Cite
|
Sign up to set email alerts
|

Moving the O-glycoproteome from form to function

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
3
2
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…In addition to glycosylation, apoC-III can also be C-terminal truncated (des-Ala and des-Ala-Ala), which further increases the number of isoforms (Bondarenko et al 1999;Jin and Manabe 2005;Nicolardi et al 2013a). Interestingly, novel results strongly suggest that glycosylation of apoC-III is an important event in the regulation of lipid metabolism (Holleboom et al 2011;Baenziger 2012). Thus, apoC-III is exclusively glycosylated by GalNAc transferase 2 (GALNT2) (Holleboom et al 2011;Schjoldager et al 2012), and heterozygotes with a loss-of-function mutation in GALNT2 present with an altered apoC-III isoform pattern with more of the non-sialylated variant and less of the monosialylated variant, while the total apoC-III plasma concentration was about the same as compared to wild-type controls (Holleboom et al 2011).…”
Section: Protein Isoforms Translational and Posttranslationalmentioning
confidence: 99%
“…In addition to glycosylation, apoC-III can also be C-terminal truncated (des-Ala and des-Ala-Ala), which further increases the number of isoforms (Bondarenko et al 1999;Jin and Manabe 2005;Nicolardi et al 2013a). Interestingly, novel results strongly suggest that glycosylation of apoC-III is an important event in the regulation of lipid metabolism (Holleboom et al 2011;Baenziger 2012). Thus, apoC-III is exclusively glycosylated by GalNAc transferase 2 (GALNT2) (Holleboom et al 2011;Schjoldager et al 2012), and heterozygotes with a loss-of-function mutation in GALNT2 present with an altered apoC-III isoform pattern with more of the non-sialylated variant and less of the monosialylated variant, while the total apoC-III plasma concentration was about the same as compared to wild-type controls (Holleboom et al 2011).…”
Section: Protein Isoforms Translational and Posttranslationalmentioning
confidence: 99%
“…However, the functional roles of GALNTs identified to date in cancer are mostly limited to their involvement in cancer cell motility or growth151718192021. Furthermore, the potential function of GALNTs on cancer progression, especially in site-specific metastasis, is poorly understood.…”
mentioning
confidence: 99%
“…Another mutation S371A/V reflects a selective sweep in Netrin-G2 protein from primates to hominins within a similar to T346A functional context when a hydrophobic alanine (in chimpanzee, A)/valine (in marmoset, V) is replaced by a polar serine (S) and a strong positive predictions for glycosylation but not phosphorylation (see SM). This poses a question about whether these two human-specific protein substitutions are associated with advanced cognitive traits as they may represent a hidden layer of poorly studied so far protein glycosylationassociated regulatomes known to affect the brain function and diseases [61,62]. In addition, T346 is nested on exon 5, just 20 nucleotides away from the rs2274855 mutation allele, affecting WM scores [1], and, together with S371A/V, they are both located within the lowest percent identity area (exons (5-7)) of Netrin-Gs (Figure 3C) and are proposed to contribute to NTNG duplicates SF.…”
Section: Evolution Of the Protein Paralogs Encoded By The Ntngsmentioning
confidence: 99%